INM.O (INM.O) News
Track canonical SquawkNews coverage tagged to INM.O, INM.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
InMed gets Nasdaq notice after stockholders’ equity falls below $2.5 million minimum
InMed received a Nasdaq notice for failing the $2.5 million minimum stockholders’ equity requirement in its fiscal 2026 Form 10-K. Stockholders’ equity was $1,075,007, putting the company at risk of delisting from the Na
MNA | Sep 18, 2026, 09:12 PM UTC
H
InMed says Mentari merger to deliver USD 490 million in gross proceeds, restore Nasdaq equity compliance
InMed is set to merge with Mentari Therapeutics under an agreement signed May 19, 2026, subject to shareholder approval. The combined company is expected to receive about USD 490 million in gross proceeds from Mentari’s
MNA | Sep 18, 2026, 08:47 PM UTC